Foreign-Trade Zone (FTZ) 49, Notification of Proposed Production Activity; Sanofi US Services Inc.; (Pharmaceutical Products); Ridgefield, New Jersey, 596 [2024-31702]
Download as PDF
<![CDATA[
596
ACTION:
Federal Register / Vol. 90, No. 3 / Monday, January 6, 2025 / Notices
Notice.
The Rural Utilities Service
(RUS or the Agency), a Rural
Development agency of the United
States Department of Agriculture
(USDA), is announcing the extension
and reopening of the Guarantees for
Bonds and Notes Issued for Utility
Infrastructure Purposes Program (the
313A Program) for Fiscal Year (FY) 2025
application window through January 31,
2025.
DATES: The application period for the
funding opportunity published October
25, 2024 at 89 FR 85148 is reopened.
Completed applications must be
electronically received by RUS no later
than 5 p.m. eastern time (ET) on January
31, 2025. Applicants intending to
submit applications must have their
applications received by the closing
deadline.
SUMMARY:
Completed applications
must be submitted electronically to
Amy McWilliams, Branch Chief, Policy
and Outreach Branch, Office of
Customer Service and Technical
Assistance, Electric Program, RUS at
amy.mcwilliams@usda.gov.
FOR FURTHER INFORMATION CONTACT:
Amy McWilliams, Branch Chief, Policy
and Outreach Branch, Office of
Customer Service and Technical
Assistance, Electric Program, Rural
Utilities Service, USDA, 1400
Independence Avenue SW, Mail Stop
1560, Room 4121-South, Washington,
DC 20250–1560, by email at
amy.mcwilliams@usda.gov, or call (202)
205–8663.
SUPPLEMENTARY INFORMATION:
ADDRESSES:
khammond on DSK9W7S144PROD with NOTICES
Background
The 313A Program guarantees loans to
selected applicants and the proceeds of
those loans are to be used for the
purpose of making utility infrastructure
loans and for refinancing bonds or notes
issued for such purposes to a borrower
that has at any time received, or is
eligible to receive, a loan under the
Rural Electrification Act of 1936, as
amended. The FY 2025 funding
opportunity for the 313A Program was
announced by a Notice of Funding
Opportunity (NOFO) published in the
Federal Register on October 25, 2024, at
89 FR 85148. Applicants should refer to
this NOFO for all details on this funding
opportunity.
VerDate Sep<11>2014
19:04 Jan 03, 2025
Jkt 265001
With this notice, RUS is reopening the
December 24, 2024, application
deadline and extending it until 5 p.m.
ET on January 31, 2025.
DEPARTMENT OF COMMERCE
Andrew Berke,
Administrator, Rural Utilities Service, USDA
Rural Development.
[B–62–2024]
[FR Doc. 2024–31668 Filed 1–3–25; 8:45 am]
BILLING CODE 3410–15–P
CIVIL RIGHTS COLD CASE RECORDS
REVIEW BOARD
[Agency Docket Number: CRCCRRB–2025–
0006–N]
Notice of Formal Determination on
Records Release
Civil Rights Cold Case Records
Review Board.
ACTION: Notice.
AGENCY:
The Civil Rights Cold Case
Records Review Board received 195
pages of records from the National
Archives and Records Administration
(NARA) related to seven civil rights cold
case incidents to which the Review
Board assigned the unique identifiers
2024–003–018, 2024–003–023, 2024–
003–035, 2024–003–038, 2024–003–051,
2024–003–067, and 2024–003–068.
NARA did not propose any
postponements of disclosure. On
December 20, 2024, the Review Board
determined that the records should be
publicly disclosed in the Civil Rights
Cold Case Records Collection. By
issuing this notice, the Review Board
complies with section 7(c)(4) of the
Civil Rights Cold Case Records
Collection Act of 2018 that requires the
Review Board to publish in the Federal
Register its determinations on the
disclosure or postponement of records
in the Collection no more than 14 days
after the date of its decision.
FOR FURTHER INFORMATION CONTACT:
Stephannie Oriabure, Chief of Staff,
Civil Rights Cold Case Records Review
Board, 1800 F Street NW, Washington,
DC 20405, (771) 221–0014, info@
coldcaserecords.gov.
Authority: Pub. L. 115–426, 132 Stat.
5489 (44 U.S.C. 2107).
SUMMARY:
Foreign-Trade Zones Board
Foreign-Trade Zone (FTZ) 49,
Notification of Proposed Production
Activity; Sanofi US Services Inc.;
(Pharmaceutical Products); Ridgefield,
New Jersey
Sanofi US Services Inc. submitted a
notification of proposed production
activity to the FTZ Board (the Board) for
its facilities in Ridgefield, New Jersey
within FTZ 49. The notification
conforming to the requirements of the
Board’s regulations (15 CFR 400.22) was
received on December 18, 2024.
Pursuant to 15 CFR 400.14(b), FTZ
production activity would be limited to
the specific foreign-status material(s)/
component(s) and specific finished
product(s) described in the submitted
notification (summarized below) and
subsequently authorized by the Board.
The benefits that may stem from
conducting production activity under
FTZ procedures are explained in the
background section of the Board’s
website—accessible via www.trade.gov/
ftz.
The proposed finished product is
Beyfortus® (Nirsevimab)—dosage form
vaccine (duty-free).
The proposed foreign-status
materials/components include
Beyfortus® (Nirsevimab monoclonal
antibody active pharmaceutical
ingredient)—unmixed and mixed drug
substance (duty-free).
Public comment is invited from
interested parties. Submissions shall be
addressed to the Board’s Executive
Secretary and sent to: ftz@trade.gov. The
closing period for their receipt is
February 18, 2025.
A copy of the notification will be
available for public inspection in the
‘‘Online FTZ Information System’’
section of the Board’s website.
For further information, contact Diane
Finver at Diane.Finver@trade.gov.
Dated: December 30, 2024.
Stephannie Oriabure,
Chief of Staff.
Dated: December 31, 2024.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2024–31618 Filed 1–3–25; 8:45 am]
[FR Doc. 2024–31702 Filed 1–3–25; 8:45 am]
BILLING CODE 6820–SY–P
BILLING CODE 3510–DS–P
PO 00000
Frm 00014
Fmt 4703
Sfmt 4703
E:\FR\FM\06JAN1.SGM
06JAN1
]]>Agencies
[Federal Register Volume 90, Number 3 (Monday, January 6, 2025)]
[Notices]
[Page 596]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-31702]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-62-2024]
Foreign-Trade Zone (FTZ) 49, Notification of Proposed Production
Activity; Sanofi US Services Inc.; (Pharmaceutical Products);
Ridgefield, New Jersey
Sanofi US Services Inc. submitted a notification of proposed
production activity to the FTZ Board (the Board) for its facilities in
Ridgefield, New Jersey within FTZ 49. The notification conforming to
the requirements of the Board's regulations (15 CFR 400.22) was
received on December 18, 2024.
Pursuant to 15 CFR 400.14(b), FTZ production activity would be
limited to the specific foreign-status material(s)/component(s) and
specific finished product(s) described in the submitted notification
(summarized below) and subsequently authorized by the Board. The
benefits that may stem from conducting production activity under FTZ
procedures are explained in the background section of the Board's
website--accessible via www.trade.gov/ftz.
The proposed finished product is Beyfortus[supreg] (Nirsevimab)--
dosage form vaccine (duty-free).
The proposed foreign-status materials/components include
Beyfortus[supreg] (Nirsevimab monoclonal antibody active pharmaceutical
ingredient)--unmixed and mixed drug substance (duty-free).
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
[email protected]. The closing period for their receipt is February 18,
2025.
A copy of the notification will be available for public inspection
in the ``Online FTZ Information System'' section of the Board's
website.
For further information, contact Diane Finver at
[email protected].
Dated: December 31, 2024.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2024-31702 Filed 1-3-25; 8:45 am]
BILLING CODE 3510-DS-P
